JP2010090149A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010090149A5 JP2010090149A5 JP2009279362A JP2009279362A JP2010090149A5 JP 2010090149 A5 JP2010090149 A5 JP 2010090149A5 JP 2009279362 A JP2009279362 A JP 2009279362A JP 2009279362 A JP2009279362 A JP 2009279362A JP 2010090149 A5 JP2010090149 A5 JP 2010090149A5
- Authority
- JP
- Japan
- Prior art keywords
- cooh
- following formula
- carbon atoms
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 1
- 150000001495 arsenic compounds Chemical class 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34649202P | 2002-01-07 | 2002-01-07 | |
| US60/346,492 | 2002-01-07 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003557380A Division JP4571408B2 (ja) | 2002-01-07 | 2003-01-07 | 癌治療薬としての、ｓ−ジメチルアルシノ−チオコハク酸、ｓ−ジメチルアルシノ−２−チオ安息香酸、ｓ−（ジメチルアルシノ）グルタチオン |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013172071A Division JP2013237701A (ja) | 2002-01-07 | 2013-08-22 | 癌治療薬としての、ｓ−ジメチルアルシノ−チオコハク酸、ｓ−ジメチルアルシノ−２−チオ安息香酸、ｓ−（ジメチルアルシノ）グルタチオン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010090149A JP2010090149A (ja) | 2010-04-22 |
| JP2010090149A5 true JP2010090149A5 (enExample) | 2012-03-01 |
| JP5603593B2 JP5603593B2 (ja) | 2014-10-08 |
Family
ID=23359639
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003557380A Expired - Lifetime JP4571408B2 (ja) | 2002-01-07 | 2003-01-07 | 癌治療薬としての、ｓ−ジメチルアルシノ−チオコハク酸、ｓ−ジメチルアルシノ−２−チオ安息香酸、ｓ−（ジメチルアルシノ）グルタチオン |
| JP2009279362A Expired - Fee Related JP5603593B2 (ja) | 2002-01-07 | 2009-12-09 | 癌治療薬としての、ｓ−ジメチルアルシノ−チオコハク酸、ｓ−ジメチルアルシノ−２−チオ安息香酸、ｓ−（ジメチルアルシノ）グルタチオン |
| JP2013172071A Pending JP2013237701A (ja) | 2002-01-07 | 2013-08-22 | 癌治療薬としての、ｓ−ジメチルアルシノ−チオコハク酸、ｓ−ジメチルアルシノ−２−チオ安息香酸、ｓ−（ジメチルアルシノ）グルタチオン |
| JP2015051753A Pending JP2015120745A (ja) | 2002-01-07 | 2015-03-16 | 癌治療薬としての、ｓ−ジメチルアルシノ−チオコハク酸、ｓ−ジメチルアルシノ−２−チオ安息香酸、ｓ−（ジメチルアルシノ）グルタチオン |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003557380A Expired - Lifetime JP4571408B2 (ja) | 2002-01-07 | 2003-01-07 | 癌治療薬としての、ｓ−ジメチルアルシノ−チオコハク酸、ｓ−ジメチルアルシノ−２−チオ安息香酸、ｓ−（ジメチルアルシノ）グルタチオン |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013172071A Pending JP2013237701A (ja) | 2002-01-07 | 2013-08-22 | 癌治療薬としての、ｓ−ジメチルアルシノ−チオコハク酸、ｓ−ジメチルアルシノ−２−チオ安息香酸、ｓ−（ジメチルアルシノ）グルタチオン |
| JP2015051753A Pending JP2015120745A (ja) | 2002-01-07 | 2015-03-16 | 癌治療薬としての、ｓ−ジメチルアルシノ−チオコハク酸、ｓ−ジメチルアルシノ−２−チオ安息香酸、ｓ−（ジメチルアルシノ）グルタチオン |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US6911471B2 (enExample) |
| EP (3) | EP1474128B1 (enExample) |
| JP (4) | JP4571408B2 (enExample) |
| AU (1) | AU2003207455B2 (enExample) |
| CA (1) | CA2472633C (enExample) |
| WO (1) | WO2003057012A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1474128B1 (en) * | 2002-01-07 | 2016-06-01 | Board Of Regents, The University Of Texas System | S-dimethylarsino-thiosuccinic acid, s-dimethylarsino-2-thiobenzoic acid, s-(dimethylarsino)glutathione as treatments for cancer |
| AU2011204901B2 (en) * | 2004-07-16 | 2013-09-12 | Board Of Regents, The University Of Texas System | Compounds and methods for treatment of cancer |
| TWI411431B (zh) * | 2004-07-16 | 2013-10-11 | Texas A & M Univ Sys | 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物 |
| JP4994374B2 (ja) * | 2005-07-29 | 2012-08-08 | ジオファーム オンコロジー， インコーポレイテッド | がんを治療するための化合物および方法 |
| WO2007082104A2 (en) * | 2006-01-13 | 2007-07-19 | The Texas A & M University System | Compounds and methods for the treatment of cancer |
| TW200829261A (en) * | 2006-09-29 | 2008-07-16 | Ziopharm Oncology Inc | Method for controlling angiogenesis in animals |
| CN101595115B (zh) * | 2006-11-01 | 2012-07-18 | 新南部创新有限公司 | 有机-氧化砷化合物及其用途 |
| EP2209480B1 (en) * | 2007-11-02 | 2012-09-05 | Ziopharm Oncology, Inc. | Combination therapy with organic arsenicals |
| CA2705467A1 (en) * | 2007-12-12 | 2009-06-18 | Ziopharm Oncology, Inc. | Compounds and methods for the treatment of cancer |
| CA2724512A1 (en) * | 2008-05-28 | 2009-12-23 | Bennard Van Ravenzwaay | Means and methods for assessing liver enzyme induction |
| WO2010021928A1 (en) | 2008-08-20 | 2010-02-25 | Ziopharm Oncology, Inc. | Organoarsenic compounds and methods for the treatment of cancer |
| JP5469779B2 (ja) * | 2010-04-19 | 2014-04-16 | エスアールアイ インターナショナル | 多発性骨髄腫の治療のための組成物および方法 |
| WO2015085208A1 (en) * | 2013-12-05 | 2015-06-11 | Solasia Pharma K.K. | Compounds and methods for the treatment of cancer |
| CN112941027B (zh) * | 2021-03-19 | 2021-11-02 | 苏州大学 | 二甲基亚胂酸致人角质形成细胞恶性转化细胞株及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2349729A (en) * | 1940-08-24 | 1944-05-23 | Parke Davis & Co | Therapeutic arsenic preparation |
| US2701812A (en) * | 1951-06-26 | 1955-02-08 | Dainippon Pharmaceutical Co | Diarylarsenious acid derivatives and the preparation thereof |
| DE3229565A1 (de) * | 1982-08-07 | 1984-02-16 | Etschenberg, Eugen, Dr., 5000 Köln | Arsenhaltige nucleoside |
| FR2640269B1 (fr) * | 1988-12-13 | 1991-03-15 | Maes Ludo | Composes organometalliques, leurs modes de preparation et compositions pharmaceutiques les contenant |
| CN1282218A (zh) * | 1997-10-15 | 2001-01-31 | 波拉克斯生物药品 | 使用砷化合物治疗原发性及转移性肿瘤疾病的组合物及方法 |
| DK2255800T3 (da) * | 1997-11-10 | 2013-02-04 | Sloan Kettering Inst Cancer | Arsentrioxid til anvendelse ved behandling af leukæmi |
| CN1233476A (zh) | 1998-04-24 | 1999-11-03 | 陆道培 | 治疗急性白血病的药物及其制备方法 |
| EP1002537A1 (en) | 1998-10-30 | 2000-05-24 | Assistance Publique, Hopitaux De Paris | Use of melarsoprol for the manufacture of a medicament for treating B-cell lymphoproliferative diseases, such as multiple myeloma |
| US6191123B1 (en) * | 1999-03-19 | 2001-02-20 | Parker Hughes Institute | Organic-arsenic compounds |
| AUPQ296799A0 (en) | 1999-09-20 | 1999-10-14 | Unisearch Limited | A cell-membrane impermeable trivalent organoarsenical derivative and use thereof |
| IL152433A0 (en) * | 2000-04-26 | 2003-05-29 | Univ Oregon Health Sciences | Administration of a thiol-based chemoprotectant compound |
| AUPR379801A0 (en) | 2001-03-19 | 2001-04-12 | Unisearch Limited | Use of a substantially cell membrane impermeable compound for treating arthritis |
| AUPR598901A0 (en) | 2001-06-28 | 2001-07-19 | Unisearch Limited | Inhibition of angiogenesis by targeting protein tyrosine phosphatases |
| AU2001272189B2 (en) | 2001-07-06 | 2008-10-09 | Cochlear Limited | Configuration of implanted devices |
| EP1474128B1 (en) * | 2002-01-07 | 2016-06-01 | Board Of Regents, The University Of Texas System | S-dimethylarsino-thiosuccinic acid, s-dimethylarsino-2-thiobenzoic acid, s-(dimethylarsino)glutathione as treatments for cancer |
| CN101863958B (zh) | 2002-11-07 | 2012-07-18 | 新南创新私人有限公司 | 对线粒体通透性转换的诱导 |
| TWI411431B (zh) | 2004-07-16 | 2013-10-11 | Texas A & M Univ Sys | 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物 |
| CN101595115B (zh) | 2006-11-01 | 2012-07-18 | 新南部创新有限公司 | 有机-氧化砷化合物及其用途 |
-
2003
- 2003-01-07 EP EP03705662.9A patent/EP1474128B1/en not_active Expired - Lifetime
- 2003-01-07 CA CA2472633A patent/CA2472633C/en not_active Expired - Fee Related
- 2003-01-07 US US10/337,969 patent/US6911471B2/en not_active Expired - Lifetime
- 2003-01-07 EP EP20110187261 patent/EP2420229A1/en not_active Withdrawn
- 2003-01-07 WO PCT/US2003/000281 patent/WO2003057012A2/en not_active Ceased
- 2003-01-07 JP JP2003557380A patent/JP4571408B2/ja not_active Expired - Lifetime
- 2003-01-07 AU AU2003207455A patent/AU2003207455B2/en not_active Ceased
- 2003-01-07 EP EP11187256A patent/EP2462932A1/en not_active Withdrawn
-
2005
- 2005-01-13 US US11/035,178 patent/US6995188B2/en not_active Expired - Lifetime
-
2006
- 2006-02-06 US US11/349,043 patent/US7619000B2/en not_active Expired - Lifetime
-
2007
- 2007-08-20 US US11/894,807 patent/US20080090904A1/en not_active Abandoned
-
2009
- 2009-12-09 JP JP2009279362A patent/JP5603593B2/ja not_active Expired - Fee Related
-
2013
- 2013-08-22 JP JP2013172071A patent/JP2013237701A/ja active Pending
-
2015
- 2015-03-16 JP JP2015051753A patent/JP2015120745A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009530398A5 (enExample) | ||
| JP2010077141A5 (enExample) | ||
| JP2013519632A5 (enExample) | ||
| JP2010523476A5 (enExample) | ||
| JP2008195730A5 (enExample) | ||
| JP2013514980A5 (enExample) | ||
| JP2012506896A5 (enExample) | ||
| JP2016534063A5 (enExample) | ||
| JP2009524675A5 (enExample) | ||
| JP2008543854A5 (enExample) | ||
| JP2016527277A5 (enExample) | ||
| JP2008509953A5 (enExample) | ||
| JP2013518107A5 (enExample) | ||
| JP2010504343A5 (enExample) | ||
| JP2020097577A5 (enExample) | ||
| RU2013119966A (ru) | Композиция, улучшающая растворимость плохорастворимого лекарственного препарата | |
| JP2012513416A5 (enExample) | ||
| JP2011527345A5 (enExample) | ||
| JP2014530818A5 (enExample) | ||
| RU2011113967A (ru) | Новое производное простагландина i2 | |
| JP2008546770A5 (enExample) | ||
| JP2011046708A5 (enExample) | ||
| JP2013518036A5 (enExample) | ||
| JP2013502461A5 (enExample) | ||
| JP2011526286A5 (enExample) |